Reuters reported on Wednesday that the U.S. judge, Kimba Wood had thrown out a lawsuit by former Novartis sales representative-turned-whistleblower Stephen Camburn against Novartis (NYSE: NVS). This lawsuit alleged that the Swiss pharma giant had paid kickbacks to doctors via a bogus speaker program to promote multiple sclerosis therapy Gilenya.
Judge Wood said that Camburn had failed to provide more details to support his claims. Camburn had claimed in his lawsuit that Novartis had paid doctors up to $3,500 to participate as speakers in educational events to convince them to promote and prescribe Gilenya.
Camburn’s lawyer told Reuters that his client would appeal against this decision in the Second Circuit Court.